These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8845828)

  • 1. The effects of the serotonin1A receptor agonist buspirone on tolbutamide-induced hypoglycemia in rats.
    Sugimoto Y; Yamada J; Kimura I; Horisaka K
    Biol Pharm Bull; 1995 Sep; 18(9):1296-8. PubMed ID: 8845828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Jpn J Pharmacol; 1992 Oct; 60(2):145-8. PubMed ID: 1479742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice.
    Sugimoto Y; Takashima N; Noma T; Yamada J
    J Pharmacol Sci; 2003 Dec; 93(4):446-50. PubMed ID: 14737015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).
    Sugimoto Y; Takashima N; Noma T; Yamada J
    Biol Pharm Bull; 2005 Apr; 28(4):733-5. PubMed ID: 15802819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
    Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
    McAllister-Williams RH; Massey AE
    Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans.
    Chiodera P; Volpi R; Capretti L; Caffarri G; Magotti MG; Coiro V
    Neuropeptides; 1996 Apr; 30(2):187-92. PubMed ID: 8771561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.
    Yamada J; Sugimoto Y; Noma T; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(1):81-6. PubMed ID: 9831297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain.
    Okazawa H; Yamane F; Blier P; Diksic M
    J Neurochem; 1999 May; 72(5):2022-31. PubMed ID: 10217280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 Feb; 177(1-2):107-10. PubMed ID: 2340854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of tryptamine on tolbutamide-induced hypoglycemia in mice: mediation by 5-HT receptors.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Neurochem Res; 1994 Jan; 19(1):19-22. PubMed ID: 8139757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release.
    Matos FF; Urban C; Yocca FD
    J Neural Transm (Vienna); 1996; 103(1-2):173-90. PubMed ID: 9026372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
    Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C
    Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat.
    Pan L; Gilbert F
    Neuroendocrinology; 1992 Dec; 56(6):797-802. PubMed ID: 1369587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity.
    Astier B; Lambás Señas L; Soulière F; Schmitt P; Urbain N; Rentero N; Bert L; Denoroy L; Renaud B; Lesourd M; Muñoz C; Chouvet G
    Eur J Pharmacol; 2003 Jan; 459(1):17-26. PubMed ID: 12505530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.